Summary Two polyclonal rabbit antibodies to epithelial membrane antogen (EMA), two mouse monoclonal antibodies (E29 and HMFG-2), and a "cocktail" of these two monoclonals have been compared using an indirect immunoperoxidase technique. Sections from 25 tissues (17 malignant and 8 benign), were examined. The distribution of staining with each of these reagents was similar, but the polyclonal antibodies produced stronger staining in colorectal carcinomas and lactating breast, whereas staining with the monoclonal antibodies was stronger in non-neoplastic pleural mesothelium and in pulmonary alveolar cells. When the two monoclonals were mixed there was no increase in staining intensity. E29 gave a "cleaner" result than HMFG-2, with better discrimination between cells and stroma, and is highly suitable for routine diagnostic histopathology.
Antibodies to human milk fat globule membranes (HMFG) (Ceriani et al., 1977) , have been shown to react with normal and neoplastic epithelium in a wide variety of sites Sloane et al., 1980a, b; Gusterson et al., 1982; Bamford et al., 1983; Heyderman et al., 1984a,b) . The glycoprotein with which these antisera react has been termed epithelial membrane antigen (EMA), since the staining in normal epithelial tissues, as well as in well-to-moderately differentiated adenocarcinomas, is mainly on the luminal or plasma membrane. The antigen has been partially purified, and shown to consist of a heterogeneous glycoprotein(s) of high mol. wt. It has been suggested that carbohydrate forms the major antigenic determinant, the principal sugars being galactose and N-acetylglucosamine .
All the breast carcinomas in the published series, and the majority of adenocarcinomas from a variety of sites, have been positive for EMA, while sarcomas and neural tumours have been reported to be negative. A few lymphomas (Sloane et (Dearnaley et al., 1983; Delsol et al., 1984; Heyderman et al., 1984a) .
Antisera to EMA have been used for the detection of bone marrow and lymph node metastases from breast carcinoma (Heyderman et al., 1979; Sloane et al., 1980a,b; Gugliotta et al., 1981; Dearnaley et al., 1981 Dearnaley et al., , 1983 Redding et al., 1983) , and for identification of malignant cells in serous effusions Epenetos et al., 1982) .
The value of EMA in tumour pathology has been established by these investigations, but further studies have been limited by shortage of sufficient antisera suitable for immunocytochemistry. Two monoclonal antibodies were raised against a preparation of milk fat globule membranes (Cordell et al., 1985 unpublished (Nakane & Kawaoi, 1974) . Endogenous peroxidase was inhibited by a sequence of hydrogen peroxide, periodic acid and potassium borohydride (Table I ) (Heyderman, 1979) .
The appropriate dilution of all the antibodies was assessed on a breast carcinoma used in our previous EMA studies, and the dilution of the five anti-EMA reagents was adjusted to give a similar staining intensity. The unpurified rabbit antibody (Dr Ormerod, ICR) was used diluted 1:1000, the affinity-purified polyclonal at 1:25, E29 at 1:25, and HMFG-2 at 1:10. The monoclonals were mixed to give the same final dilutions.
Tissues and controls All 25 tissues used in this study (Table II) were chosen from cases found to be positive with the affinity-purified rabbit anti-EMA antibody, so that no positive control was required. Twenty-four were formalin-fixed paraffin-embedded blocks from the St Thomas Hospital files. The other specimen, a paraffin-embedded first trimester placenta, had been fixed in Bouin's solution.
As the object of this investigation was to compare the distribution of staining with these four antibodies, rather than to establish their specificity, no negative 'absorbed' control was used. Use of both the anti-rabbit and anti-mouse immunoglobulin peroxidase conjugates in a number of previous studies (Heyderman, 1983; 1984a, b; Graham et al., 1985) had indicated that neither of them showed evidence of anti-human activity. Neither of them stained tissue sections when an inappropriate or absorbed negative control serum had been used. Antibodies A rabbit polyclonal antiserum to EMA was a generous gift from Dr Ormerod (ICR, Sutton) , and the monoclonal antibody HMFG-2 was a gift from Seward Laboratories.
Affinity-purified antibodies to EMA were Note 0.02% azide is required in the 1% ovalbumin in PBS used for diluting first (specific) antibodies to be stored at 4°C. It is optional in the PBS used for washing. It should be omitted from 1% ovalbumin to be used for diluting peroxidase conjugates since it is deleterious (Richardson et al., 1983) . Diluted conjugates may be stored in aliquots at -20°C. prepared at St Thomas Hospital (TCR), and the monoclonal E29 at Oxford (JLC) using the immunogen prepared as below (TCR).
Preparation of EMA Cream was separated from whole human milk by low speed centrifugation (2000g, 20min). The lipid layer was skimmed off and resuspended in saline (NaCI0.15moll-1). The centrifugation and resuspension were repeated twice, and the lipid was finally resuspended in saline to give a 33% w/v mixture and frozen at -20°C overnight. The mixture was then thawed at 37°C and the cloudy aqueous layer centrifuged at high speed (40,000g 1 h) to yield a pellet of milk fat globule membranes (Kobylka & Carraway, 1972) . This was centrifuged and resuspended three times in saline, and used for the immunisation of rabbits.
Residual EMA in the lipid layer was extracted with the mixture of monoclonals. When HMFG-2 The lipid was dissolved by adding a mixture of equal volumes of chloroform and saline, shaking and allowing to stand for 1 h at room temperature. The upper aqueous layer was extracted again with chloroform, and allowed to stand for a further hour. The aqueous layer was then removed and extracted twice with equivalent volumes of ether. The slightly cloudy lower aqueous layer was removed, and residual ether evaporated using nitrogen gas. This delipidated extract in saline was used for the immunisation of mice (Cordell et al., 1985) . The protein content of the milk fat globule membrane preparation was determined by the Coomassie blue dye-binding assay (Bradofrd, 1976) .
Affinity chromatography
The EMA antisera raised in rabbits were purified on an Affi-Gel 10 column. This is an agarose containing active n-hydroxysuccinimide bonds (Cuatrecasas & Parikh, 1972 ) (BioRad Laboratories, Herts) to which purified EMA (non-chloroform/ ether extracted) had been bound. The antiserum was applied to the column, left for 1 h, and unbound proteins and non-specific antibodies were washed off with PBS (0.15moll-1, pH7.3). The bound EMA-specific antibodies were eluted with guanidine (3 mol l-1, pH 3). The eluate containing the affinity-purified antibody was immediately dialysed against PBS to remove any remaining guanidine which could have caused denaturation of the antibodies.
Results
All of the sections showed positive staining with all of the antibodies. The distribution of staining with either of the four antibodies or with the monoclonal 'cocktail' of E29 and HMFG-2 was similar. Both in normal and neoplastic tissues there was some heterogeneity of staining, less marked in sections from non-neoplastic tissues. Where the staining was on the luminal membrane of glandular tissues it tended to be of fairly uniform intensity. In the breast carcinomas most of the acini were positive, including intracellular microacini, whereas in the colorectal tumours only some acini were stained. Cytoplasmic staining of tumours was much more variable, with some morphologically similar cells negative and others positive.
Discrimination between epithelial tissues and stroma was excellent with the two polyclonal antibodies and with E29. (Figures 1 and 2 ), but a brownish tinge of staining in the connective tissue was frequently found when HMFG-2 was used, and with the mixture of monoclonals. When HMFG-2 was diluted further, the intensity of staining of the test section of breast carcinoma showed an equal decrease in staining of tumour and stroma. There was no increase in staining intensity when the 'cocktail' was used, compared with the individual monoclonal antibodies.
There were, however, minor differences. The distribution of staining with polyclonal antibodies in the breast carcinomas was mainly luminal (Figure 3 ) with some cytoplasmic staining particularly in more poorly differentiated areas. With the monoclonal antibodies, there was a tendency for the staining to be more cytoplasmic, rather than confined to the luminal aspect of malignant acini (Figure 4) . Staining of the colonic carcinomas (Figures 5 and 6 ) and the lactating breast was stronger with the polyclonals (Figure 7 ) than with the monoclonal antibodies (not shown). The non-malignant mesothelium and alveolar membranes surrounding the lung tumours were stained more strongly with the monoclonal antibodies, than with the polyclonals. All of the antibodies stained the dense intradermal infiltrate :., -o8 ; Figure 7 Section of lactating breast stained with purified polyclonal (x 40).
of plasma cells close to the squamous carcinoma of the skin used for this study.
Discussion
The use of diagnostic histopathology of polyclonal antibodies to EMA, a large glycoprotein present on many benign and malignant epithelial membranes, is well established. Polyclonal anti-EMA antibodies have the disadvantages that they are available in limited quantity, that the quality of the antisera may vary from bleed to bleed, and that affinitypurification yields are small. Monoclonal antibodies, produced by the hybridoma system (Kohler & Milstein, 1975) , can be produced in large amounts with substantially less inter-batch variation. However, monoclonal antibodies have the disadvantage that if the determinant recognised is shared by the tissues between which discrimination is required (Kemshead et al., 1981) , such unwanted cross-reactivity cannot be diluted out, as is sometimes possible with polyclonal antibodies. The concentration of antibodies used in this study was determined on the test breast carcinoma and the intensity of staining of the tumour cells matched. With an antibody like HMFG-2, which also stained the stroma, further dilution reduced the intensity of stromal staining, but also reduced the intensity of tumour staining. As with polyclonal antibodies, discrimination between positive and negative areas may be lost when the antibody concentration of monoclonals is increased too far (Ciocca et al., 1983) .
A possible approach is to use mixtures of well characterised monoclonal antibodies as hybridoma 'cocktails'. Although this study did not result in any increase in intensity of staining, it also did not demonstrate any steric hindrance which might have occurred with two antibodies reacting with what are probably closely related epitopes. Further studies, using cocktails of antibodies to EMA, carcinoembryonic antigen and cytokeratin are in progress for evaluation of apparently undifferentiated (anaplastic) tumours.
Since monoclonal antibodies recognise only one antigenic epitope, and polyclonal antibodies may recognise a range of determinants, this may account for differences in staining intensity and distribution. However, these results and our subsequent use of E29 in diagnostic histopathology, have not shown any significant difference in distribution of staining between E29 and our previously used affinitypurified rabbit antibody. Like the polyclonal antibodies, E29 stains decalcified tissues and can be used for the detection of bone marrow metastases. This reagent is now in routine use in our departments in a panel of antibodies used for the evaluation of tumours of uncertain origin.
